President and Chief Executive Officer

Senior Vice President, Franchise Head Epilepsy and Movement Disorders

Jazz Pharmaceuticals Director Sells 5,500 Shares

FDA Approves Jazz Pharmaceuticals plc's Zepzelca (lurbinectedin) and Atezolizumab Combination as First-Line Maintenance Therapy for Extensive-Stage Small Cell Lung Cancer

FDA Approves Zepzelca® (lurbinectedin) and Atezolizumab (Tecentriq®) Combination as First-Line Maintenance Therapy for Extensive-Stage Small Cell Lung Cancer

FDA Approves Genentech’s Tecentriq Plus Lurbinectedin as First-Line Maintenance Therapy for Extensive-Stage Small Cell Lung Cancer

Senior Manager, Learning & Development Center of Excellence – Epilepsy and Movement Disorders

Jazz Pharmaceuticals is a global biopharma company dedicated to developing life-changing medicines for patients with serious diseases. The Senior Manager, Learning & Development – Epilepsy and Movement Disorders will lead the design and delivery of training programs for the EMD field force, focusing on enhancing team capabilities and driving strategic learning initiatives.

Senior Manager, Learning & Development Center of Excellence – Epilepsy and Movement Disorders (Remote)

Associate Director, R&D Training, Head R&D Process and Training

Senior Manager, HR Programs & Project Excellence

Director, Patient Centered Outcomes

US Medical Affairs Senior Manager – Training, Operations, and Planning

Associate Director - Oxybate Patient Access & Services 

Sign up with Google

Sign in with Google